Dr. Chris Beyrer, Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA's plan to clear a third dose of Covid vaccines for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Technology Reporter Drake Bennett explain that as incentives fail to entice people to get vaccinated, businesses are now looking to employee mandates. Bloomberg Opinion Columnist Tara Lachapelle breaks down why even Disney profits are not safe from the delta variant. And we Drive to the Close with Mace McCain, Chief Investment Officer at Frost Investment Advisors.

Host: Carol Massar. Producer: Paul Brennan.

Dr. Chris Beyrer, Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA's plan to clear a third dose of Covid vaccines for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Technology Reporter Drake Bennett explain that as incentives fail to entice people to get vaccinated, businesses are now looking to employee mandates. Bloomberg Opinion Columnist Tara Lachapelle breaks down why even Disney profits are not safe from the delta variant. And we Drive to the Close with Mace McCain, Chief Investment Officer at Frost Investment Advisors.Host: Carol Massar. Producer: Paul Brennan.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

FDA Set to Clear Third Covid Shot for Immunocompromised

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/636e47b4-002e-4aed-8b77-ae2b002a60ad/transcript

Advertisement